
    
      tDCS and RAT will be used in chronic stroke patients to improve a variety of functions such
      as motor functions with upper limb.

      tDCS will be applied in a placebo-controlled, double-blind, randomised fashion. A session of
      RAT will be associated with tDCS/placebo. Behavioural data will be collected before and after
      tDCS, associated with RAT.
    
  